Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hidrocystoma × Dexmedetomidine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain, Postoperative 7 Brain Neoplasms 6 Breast Neoplasms 5 Neoplasms 4 Thyroid Neoplasms 3 Agnosia 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Pheochromocytoma 2 Lung Neoplasms 2 Liver Neoplasms 2 Dexmedetomidine 2 Chronic Pain 2 Supratentorial Neoplasms 1 Sleep Initiation and Maintenance Disorders 1 Sigmoid Neoplasms 1 Seizures 1 Prostatic Hyperplasia 1 Postoperative Nausea and Vomiting 1 Postoperative Analgesia 1 Pneumoperitoneum 1 Pancreatic Neoplasms 1 Pain, Intractable 1 Obesity 1 Neuroinflammatory Diseases 1 Neurofibromatoses 1 Neurocognitive Disorders 1 Neoplasm Metastasis 1

Interventions

Sodium Chloride 1 Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04932746 2023-02-17

RCT

Damascus University

Phase NA Completed

Gastrointestinal

Abscess, Esophageal Atresia, Hidrocystoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡